Connect with us

Health

CEPI Expands Partnership with Clover Biopharmaceuticals to Rapidly Advance Development and Manufacture of COVID-19 Vaccine Candidate – Yahoo Finance

CEPI, the Coalition for Epidemic Preparedness Innovations, today announced the expansion of its partnership with Sichuan Clover Biopharmaceuticals, Inc (China) (“Clover”) to rapidly advance the development and manufacture of Clover’s protein-based COVID-19 S-…

Published

on

post featured image
ADVERTISEMENT
  • CEPI to invest an additional $66m upfront in Clovers S-Trimer protein vaccine candidate.
  • Funding will support clinical development in parallel with scale-up of manufacturing capacity …

    Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending